Home > 2014 ICD-9-CM Diagnosis Codes > Supplementary Classification Of Factors Influencing Health Status And Contact With Health Services V01-V91 > Persons With Potential Health Hazards Related To Communicable Diseases V01-V09 > Need for isolation and other prophylactic measures V07-
Non-specific code 2014 ICD-9-CM Diagnosis Code V07.5
Use of agents affecting estrogen receptors and estrogen levels
  • 2014
  • Non-Billable Code

  • There are 3 ICD-9-CM codes below V07.5 that define this diagnosis in greater detail. Do not use this code on a reimbursement claim.
  • You are viewing the 2014 version of ICD-9-CM V07.5.
  • More recent version(s) of ICD-9-CM V07.5: 2015.
V07.5 Excludes
  • hormone replacement therapy (postmenopausal) (V07.4)
Code First
  • Code first, if applicable:
Use Additional
  • Use additional code, if applicable, to identify:
    • estrogen receptor positive status (V86.0)
    • family history of breast cancer (V16.3)
    • genetic susceptibility to cancer (V84.01-V84.09)
    • personal history of breast cancer (V10.3)
    • personal history of prostate cancer (V10.46)
    • postmenopausal status (V49.81)
 V07.4 ICD9Data.com V07.51 
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM V07.5 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2014 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.
Free ICD-9-CM Codes
Site Information
Free ICD-10-CM/PCS Codes
Free HCPCS Codes